Search

Your search keyword '"Denis Fouque"' showing total 229 results

Search Constraints

Start Over You searched for: Author "Denis Fouque" Remove constraint Author: "Denis Fouque" Topic internal medicine Remove constraint Topic: internal medicine
229 results on '"Denis Fouque"'

Search Results

1. Situation of the Covid-19 epidemic in patients on peritoneal dialysis on 2020/05/15 in France : RDPLF data-base

2. Retraction: First viral replication of Covid-19 identified in the peritoneal dialysis fluid

3. First viral replication of Covid-19 identified in the peritoneal dialysis fluid of a symptomatic patient

4. Resistance Exercise Program: Intervention To Reduce Inflammation And Improve Nutritional Status In Hemodialysis Patients

5. Using A Web-Based Nutrition Algorithm In Hemodialysis (Hd) Patients

6. Role of lipotoxicity in insulin resistance in subtotally nephrectomized mouse model

7. inflammation increases the resting energy expenditure in hemodialysis patients

8. Prebiotics improve metabolic parameter in uremic mice by reducing intestinal production of p-cresyl sulfate

9. Acidosis, cognitive dysfunction and motor impairments in patients with kidney disease

10. New insights into acute-on-chronic kidney disease in nephrology patients: the CKD-REIN study

11. Urgent-start dialysis in patients referred early to a nephrologist-the CKD-REIN prospective cohort study

12. The effect of natriuretic C-type peptide and its change over time on mortality in patients on haemodialysis or haemodiafiltration

13. The unsolved challenge of implementing sustained reductions of sodium intake in patients with chronic kidney disease

14. Evolution of body composition and wasting indicators by time of day of haemodialysis

15. Urinary Sodium-to-Potassium Ratio and Blood Pressure in CKD

16. Perceived Health and Quality of Life in Patients With CKD, Including Those With Kidney Failure: Findings From National Surveys in France

17. A prospective observational study for justification, safety, and efficacy of a third dose of mRNA vaccine in patients receiving maintenance hemodialysis

18. Justification, safety, and efficacy of a third dose of mRNA vaccine in maintenance hemodialysis patients: a prospective observational study

19. Metformin misuse in chronic kidney disease

20. Bicarbonate Supplement Restores Urinary Klotho Excretion in Chronic Kidney Disease: A Pilot Study

21. MO512THE RENAL CONSEQUENCES OF LUNG TRANSPLANTATION IN ADULT CYSTIC FIBROSIS PATIENTS

22. MO484ADVERSE OUTCOMES ASSOCIATED WITH ORAL ANTITHROMBOTIC USE IN PATIENTS WITH MODERATE-TO-ADVANCED CHRONIC KIDNEY DISEASE*

23. MO461FGF19 IMPROVES GLUCOSE METABOLISM IN CKD MICE

24. Reply letter- critical comments on the impact of curcumin supplementation on expression of inflammatory transcription factors in hemodialysis patients: A pilot randomized, double-blind, controlled study

25. Can curcumin supplementation reduce plasma levels of gut-derived uremic toxins in hemodialysis patients? A pilot randomized, double-blind, controlled study

26. Is a treat-to-target approach to lipid-lowering therapy appropriate in patients with chronic kidney disease? A prospective French cohort study

27. The protein-bound uremic toxin p-cresyl-sulfate promotes intracellular ROS production and lipid peroxidation in 3T3-L1 adipose cells

28. Consequences of oral antithrombotic use in patients with chronic kidney disease

29. Natriuretic Peptides as Predictors of Protein-Energy Wasting in Hemodialysis Population

30. COVID-19 vaccine acceptance among haemodialysis patients: a French survey

31. Biologically plausible trends suggesting that a <scp>low‐protein</scp> diet may enhance the effect of flozination caused by the sodium‐glucose cotransporter‐2 inhibitor dapagliflozin on albuminuria

32. Nephrology: achieving sustainability

33. Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients

34. Using a generic definition of cachexia in patients with kidney disease receiving haemodialysis: a longitudinal (pilot) study

35. Effects of Fecal Microbiota Transplantation on Composition in Mice with CKD

36. Renal adverse effects of immune checkpoints inhibitors in clinical practice: ImmuNoTox study

37. Real-world safety and effectiveness of sucroferric oxyhydroxide for treatment of hyperphosphataemia in dialysis patients: a prospective observational study

38. Utility of phase angle to identify cachexia and assess mortality in end-stage renal disease

39. P0922A LOW AROMATIC AMINO-ACID DIET IMPROVES RENAL FUNCTION AND PREVENTS KIDNEY FIBROSIS IN MICE WITH CHRONIC KIDNEY DISEASE

40. P0388ABC-R ANCA STUDY ESTABLISHMENT OF AN ANATOMOPATHOLOGICAL BIOLOGICAL AND CLINICAL PROGNOSTIC SCORE IN THE MANAGEMENT OF ANCA VASCULITIS WITH RENAL IMPAIRMENT

41. Impact of age on cardiovascular drug use in patients with chronic kidney disease

42. Editorial: Implementing low protein diets in clinical practice in patients with chronic kidney disease

43. Myostatin and muscle atrophy during chronic kidney disease

44. Impact of curcumin supplementation on expression of inflammatory transcription factors in hemodialysis patients: A pilot randomized, double-blind, controlled study

45. Adverse Drug Reactions in Patients with CKD

46. Adverse outcomes of proton pump inhibitors in patients with chronic kidney disease: The CKD-REIN cohort study

47. Serum levels of the adipokine zinc-alpha2-glycoprotein (ZAG) predict mortality in hemodialysis patients

48. Evaluation of the adequacy of drug prescriptions in patients with chronic kidney disease: results from the CKD-REIN cohort

49. Achievement of 2009 and 2017 Kidney Disease: Improving Global Outcomes mineral and bone targets and survival in a French cohort of chronic kidney disease Stages 4 and 5 non-dialysis patients

50. The effect of high-volume online haemodiafiltration on nutritional status and body composition: the ProtEin Stores prEservaTion (PESET) study

Catalog

Books, media, physical & digital resources